Tag: NTI drugs

Narrow Therapeutic Index Drugs: Stricter Bioequivalence Requirements Explained

Narrow therapeutic index drugs require stricter bioequivalence standards to ensure patient safety. Learn how the FDA, EMA, and Health Canada differ in their rules, why generics are harder to make, and what this means for your treatment.

Combination NTI Drugs and Generic Availability: Coverage and Gaps

Combination NTI drugs offer precise treatment for serious conditions, but generic versions are nearly nonexistent due to strict bioequivalence requirements. Patients face higher risks, costs, and monitoring burdens when substitutions occur.

Medical Society Guidelines on Generic Drug Use: What Providers Really Think

Medical societies have conflicting views on generic drug substitution. While most support generics for cost savings, neurologists and others warn against swapping NTI drugs like antiepileptics due to safety risks. Here’s what providers really think.